EcoDrugPlus

Mapk Activated Protein Kinase 2b

Ensembl ID : ENSSAUG00010019349
Gene Symbol: MAPKAPK2B
1 Cross references
174 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSSAUG00010008143
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSSAUG00010008968
Gene Symbol: MKNK1
3 Cross references
167 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2b

Ensembl ID : ENSSAUG00010021405
Gene Symbol: MKNK2B
1 Cross references
208 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSSAUG00010001540
Gene Symbol: MCL1B
1 Cross references
170 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSSAUG00010024196
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSSAUG00010009028
Gene Symbol: MET
3 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSSAUG00010013764
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSSAUG00010007820
Gene Symbol: NPC1L1
3 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSAUG00010008520
Gene Symbol: LOC115588055
3 Cross references
195 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSSAUG00010009693
Gene Symbol: LOC115568591
3 Cross references
192 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSSAUG00010003849
Gene Symbol: LOC115596678
3 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).